Member Directory
Near the end of 2020, Deepmind announced that they had solved of the protein folding problem, a "50-year-old grand challenge in biology". Their approach was end-to-end deep learning, and it was the first time deep learning had solved an important scientific problem.
We believe this along with other recent breakthroughs in deep learning on 3D molecular configurations are the start of a new era in drug discovery, akin to the what AlexNet did for computer vision in 2012. Inspired by these breakthroughs, **CHARM Therapeutics** was founded with the mission to harness the power of deep learning to deliver medicines of transformational efficacy for patients.
Chesterford Research Park offers advanced laboratory and office space set within 250 acres of idyllic parkland near Cambridge – modern, dynamic, flexible facilities perfectly appointed for biotechnology, pharmaceutical and technology R&D companies of all sizes. The Park is being developed as a 250 acre low density scheme, which means that the natural environment, arboretum and wide-open spaces play a crucial role alongside the cutting-edge research facilities. Not only that, but the purpose-built hub building, The Nucleus, at the heart of the Park provides all the facilities required to make working life simple, enjoyable and rewarding - as well as fostering collaboration between the community as they meet and interact there. Home to companies that are making a real difference, scientists, investors and entrepreneurs work side by side at Chesterford Research Park, developing life-changing drugs within a sustainable environment.
CK Clinical is part of a family of science-based consultancies – The CK Group. We provide Functional Service Outsourcing services as well as helping to recruit for contract and permanent job opportunities across the UK and Europe. We aim to provide resource solutions that are tailored and cost effective to organisations ranging from small start ups to large international pharmaceutical companies. We have a track record delivering Functional Service outsourcing and contingency recruitment solutions to some of the most innovative new Biotechs right the way through to helping 9 of the top 10 major Pharma companies.
CMS is a full service law firm with a network of offices across Europe and beyond. We are leaders in the life sciences sector and have a strong track record of working with early-stage spin-outs through to major global companies. The sector presents its own unique challenges and needs. We have a team focused on building relationships and expertise required to deliver relevant advice. Our clients benefit from commercial no-nonsense advice, whether they are longstanding clients or prospective clients needing a second opinion or advice where others are conflicted. Our clients value our commercial advice, which is delivered at competitive prices.
CN Bio Innovations develops human organ-on-a-chip technologies: devices that enable the formation of miniature models of organs in the lab using living human cells. In 2016 we successsfully showcased the world's first 7-organ-on-a-chip platform. Over the past three years more than 25 pharmaceutical companies have used our devices to study the effects of drugs and other chemicals on organ function. CN Bio is also developing organ-on-a-chip models for specific diseases, including non-alcoholic steatohepatitis and hepatitis B. CN Bio is a co-recipient with MIT of a $26 million federal contract to develop next generation organs-on-chips and has also received InnovateUK grant awards.
About Codon Communications https://www.codoncommunications.com/
Codon develops curated PR solutions for transformational biotech companies at every stage to help establish brand credibility, raise awareness of their pioneering products, elevate their reputation as key opinion leaders, demonstrate corporate value to investors, and connect with customers and collaborators. Driven by PhD-level scientists with expertise in PR and marketing for bioscience companies, Codon offers a rare combination of high-level scientific understanding and more than a decade of experience in science communication. We pride ourselves on delivering scientifically sound content and a portfolio of reputation-building, audience-engaging PR for the life science industry through our trusted relationships with the trade media and global industry network.
Watch our Member Showcase video here https://bit.ly/3I0LOjF
Colorifix is a small biotech company made up of like minded people who firmly believe that sustainable practices are key to create a balance between mankind and the earth. Colorifix has developing a revolutionary dyeing process to help the textile industry dramatically reduce its environmental impact in a cost effective manner using a synthetic biology based approach. The Colorifix approach makes use of the emerging field of Synthetic Biology. In other words we are applying natures' solutions to man-made problems. We are harnessing the power of biology to create a sustainable future. Using synthetic biology we produce, deposit and fix dyes biologically, avoiding harmful chemicals whilst reducing water, energy and waste.
Watch our Member Showcase video here https://vimeo.com/622241093